Curex review
An oral line at $199 across forty-five states, with no injection offered at any price.
The verdict
Curex publishes $199 a month for oral semaglutide across 45 states. It sells no injection, which makes the figure hard to compare against an injectable price.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Oral
- States
- 45
- From
- From $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 45 states
Curex sells oral semaglutide. There is no injectable line. Coverage is recorded in forty-five states, which is wide for this category.
Who writes the prescription, and what do they see?
A prescription is issued before shipping, and the published material describes the product rather than the clinician. The intake is not documented. Nothing states what review happens before a repeat order goes out.
Remote, built around a single product rather than a menu. Committing to one format is itself a choice, and it is the clearest thing Curex publishes about how it works.
What happens when the dose goes up?
Oral dosing escalates on its own schedule, and Curex publishes nothing about what $199 covers as that happens. The gap is the same one most sellers leave, on a format where the rungs differ from the injectable ones.
What the price includes
$199 a month is $1,194 over six months at a steady dose. Setting that against an injectable figure compares two different products: the formats differ in what a milligram delivers, so the cheaper number is not automatically the cheaper treatment.
What it claims, and what it cites
Compounded rather than manufactured. A pharmacy prepares it and the FDA does not review it before dispensing. The oral route is not the one the approved weight-loss products use.
Where it holds up, and where it does not
- Strength: Coverage recorded across 45 states
- Strength: A single published figure, no tiers to decode
- Strength: No injection means no format upsell
- Limitation: Oral only — no injectable option
- Limitation: Not comparable against injection prices
- Limitation: Nothing published about dose behavior
- Limitation: Five states are not served
What the evidence says about this kind of treatment
The assessment above is about Curex. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who has decided against injections and wants one published figure.
- Wrong for
- A buyer comparing against injectable prices, or one who may want to switch formats later.
The evidence behind what Curex prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Curex compares
| Seller | Who it suits | Go |
|---|---|---|
 Coivas | Readers comparing headline figures who will ask about dose and coverage before ordering | See Coivas → |
 Bon Health | Readers who can pick a commitment length and want every rung priced before they choose | See Bon Health → |
 Amble | Buyers who want a multi-month rate that holds at every dose | See Amble → |
More GLP-1 telehealth sellers reviews: EdenEmbodyEnhance MDFoundGalaHealthRX
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $199 comparable to an injection price?
- Not directly. The formats deliver a milligram differently, so a lower or higher number across formats is not by itself the cheaper treatment.
- Does Curex sell an injection?
- No. Oral semaglutide is the only line published.
- How many states are covered?
- Forty-five are recorded. Five are not served.
- Is Curex legit?
- Curex is a GLP-1 telehealth sellers service. Its stated availability: 45 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Curex expensive compared with other GLP-1 telehealth sellers?
- Curex publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Curex above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.